Overview
A cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection. Palmidrol is available for human use as a supplement (400 mg capsules) and as food for medical purposes In Italy and Spain (300 mg and 600 mg tablets).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/02/22 | Phase 2 | Recruiting | |||
2024/01/29 | Phase 2 | Recruiting | |||
2023/10/02 | Phase 2 | Recruiting | The Israeli Medical Center for Alzheimer's | ||
2022/07/29 | Early Phase 1 | Recruiting | |||
2022/04/08 | Phase 2 | Withdrawn | |||
2022/02/18 | Phase 2 | Active, not recruiting | Academic and Community Cancer Research United | ||
2021/09/16 | Phase 3 | Completed | |||
2021/08/12 | Phase 2 | Completed | |||
2016/03/04 | Phase 4 | Completed | |||
2016/01/01 | Not Applicable | Completed | University of Roma La Sapienza |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| BLACKMORES CONCENTRATED CURCUMIN + PAIN RELIEF | 411018 | Medicine | A | 6/22/2023 | |
| LipoCap P.E.A | 486009 | Medicine | A | 4/14/2025 | |
| PEA-gesic Forte | 469606 | Medicine | A | 11/20/2024 | |
| Pain Relief PEA Forte | 446731 | Medicine | A | 4/26/2024 | |
| Eagle Clinical PEA Max | 452005 | Medicine | A | 6/13/2024 | |
| InflamaSoothe Trio | 390938 | RN Labs Pty Ltd | Medicine | A | 6/20/2022 |
| ETHICAL NUTRIENTS CLINICAL NERVALGESIC | 450575 | Medicine | A | 6/3/2024 | |
| Pain Relief+ | 491668 | Medicine | A | 6/13/2025 | |
| METAGENICS PAINX | 376652 | Medicine | A | 10/21/2021 | |
| SaffroPEA | 394691 | Medicine | A | 8/25/2022 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.